rs1244884053
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004646.4(NPHS1):c.2540_2543delCTAA(p.Thr847ArgfsTer57) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000062 in 1,613,232 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T847T) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004646.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- congenital nephrotic syndrome, Finnish typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, G2P, Labcorp Genetics (formerly Invitae), ClinGen
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NPHS1 | ENST00000378910.10 | c.2540_2543delCTAA | p.Thr847ArgfsTer57 | frameshift_variant | Exon 19 of 29 | 1 | NM_004646.4 | ENSP00000368190.4 | ||
| NPHS1 | ENST00000353632.6 | c.2540_2543delCTAA | p.Thr847ArgfsTer57 | frameshift_variant | Exon 19 of 28 | 5 | ENSP00000343634.5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461174Hom.: 0 AF XY: 0.00000825 AC XY: 6AN XY: 726892 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74272 show subpopulations
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Pathogenic:3
Variant summary: NPHS1 c.2540_2543delCTAA (p.Thr847ArgfsX57) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.2540_2543delCTAA has been reported in the literature in individuals affected with Nephrotic Syndrome, Type 1 (e.g. Santin_2009). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 19812541). ClinVar contains an entry for this variant (Variation ID: 555946). Based on the evidence outlined above, the variant was classified as pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 555946). This premature translational stop signal has been observed in individual(s) with steroid resistant nephrotic syndrome (PMID: 19812541). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr847Argfs*57) in the NPHS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NPHS1 are known to be pathogenic (PMID: 11317351, 11854170, 12039988). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at